We are live on
!
Find out more
B
Brightworth Portfolio holdings
AUM
$933M
1-Year Est. Return
15.08%
This Fund
S&P 500
This Quarter
Est. Return
-4.04%
1 Year Est. Return
-15.08%
3 Year Est. Return
+21.7%
5 Year Est. Return
+55.97%
10 Year Est. Return
–
AUM
$987M
AUM Growth
-$106M
(-9.7%)
Cap. Flow
-$51.5M
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
59.26%
Holding
131
New
8
Increased
59
Reduced
46
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$12.5M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$5.24M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$4.48M |
| 4 |
Coca-Cola
KO
|
+$4.08M |
| 5 |
Vanguard Total Bond Market
BND
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$83.5M |
| 2 |
Amgen
AMGN
|
+$4.73M |
| 3 |
Apple
AAPL
|
+$1.51M |
| 4 |
Pfizer
PFE
|
+$812K |
| 5 |
Bristol-Myers Squibb
BMY
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.34% |
| 2 | Healthcare | 6.46% |
| 3 | Consumer Staples | 5.67% |
| 4 | Consumer Discretionary | 5.16% |
| 5 | Technology | 4.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
iShares ESG Aware MSCI USA ETF
ESGU
$17.6B
| – | – |
-3,132
| Closed | -$338K |
|
127
General Mills
GIS
$19.2B
| – | – |
-4,818
| Closed | -$325K |
|
128
Global Payments
GPN
$22.1B
| – | – |
-5,073
| Closed | -$686K |
|
129
Intuit
INTU
$81.1B
| – | – |
-418
| Closed | -$269K |
|
130
Southern Company
SO
$110B
| – | – |
-7,503
| Closed | -$515K |
|
131
Vanguard Real Estate ETF
VNQ
$39.9B
| – | – |
-1,779
| Closed | -$206K |
|
Similar funds
FM
BO
CL
PS
AIL
CGM
H6H
AEPI
Brightworth's Q1 2022 Portfolio in Review
As of Q1 2022, Brightworth held 131 positions worth $987M, down 9.7% from $1.09B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Brightworth withdrew a net $51.5M in Q1 2022, closing 11 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $716K position sold in full.
By sector, the portfolio is most concentrated in Financials at 7.3% of assets, up from 7% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Brightworth opened a new position in Thermo Fisher Scientific worth $5.39M.
- Brightworth's largest Q1 2022 buy was Thermo Fisher Scientific: 9,121 shares worth $5.39M.
- Brightworth added most to Vanguard Total International Stock ETF in Q1 2022, an estimated $12.5M increase.
- Brightworth's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $83.5M.
- Brightworth fully exited Bristol-Myers Squibb in Q1 2022, selling an estimated $716K.
- Brightworth's ten largest holdings make up 59% of its $987M portfolio in Q1 2022.
- Brightworth opened 8 new positions and closed 11 in Q1 2022.
- Brightworth's portfolio value fell 9.7% quarter-over-quarter to $987M.
Based on Brightworth's 13F filing for Q1 2022, filed 29 Apr 2022.